Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
PaperCitations, authors & open-access status
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 331 citations, 2023 year and hybrid oa status.
331
Citations
2023
Year
hybrid
OA Status